ResMed Valuation
| RMD Stock | USD 233.18 0.70 0.30% |
At this time, the company appears to be overvalued. ResMed Inc holds a recent Real Value of $210.99 per share. The prevailing price of the company is $233.18. Our model determines the value of ResMed Inc from analyzing the company fundamentals such as Operating Margin of 0.32 %, return on equity of 0.24, and Shares Outstanding of 146.8 M as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting ResMed's valuation include:
Price Book 6.572 | Enterprise Value 34.6 B | Enterprise Value Ebitda 21.2673 | Price Sales 7.1415 | Forward PE 25.4453 |
Overvalued
Today
Please note that ResMed's price fluctuation is very steady at this time. Calculation of the real value of ResMed Inc is based on 3 months time horizon. Increasing ResMed's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the ResMed stock is determined by what a typical buyer is willing to pay for full or partial control of ResMed Inc. Since ResMed is currently traded on the exchange, buyers and sellers on that exchange determine the market value of ResMed Stock. However, ResMed's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 233.18 | Real 210.99 | Target 184.0 | Hype 233.01 |
The real value of ResMed Stock, also known as its intrinsic value, is the underlying worth of ResMed Inc Company, which is reflected in its stock price. It is based on ResMed's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of ResMed's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of ResMed Inc helps investors to forecast how ResMed stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of ResMed more accurately as focusing exclusively on ResMed's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use ResMed's intrinsic value based on its ongoing forecasts of ResMed's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against ResMed's closest peers. If more than one evaluation category is relevant for ResMed we suggest using both methods to arrive at a better estimate.
ResMed Cash |
|
ResMed Valuation Trend
Comparing ResMed's enterprise value against its market capitalization is a good way to estimate the value of ResMed Inc uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
ResMed Revenue by Product
ResMed Total Value Analysis
ResMed Inc is at this time expected to have company total value of 34.57 B with market capitalization of 34.33 B, debt of 873.93 M, and cash on hands of 273.71 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the ResMed fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
34.57 B | 34.33 B | 873.93 M | 273.71 M |
ResMed Investor Information
About 61.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 1.77. ResMed Inc recorded earning per share (EPS) of 7.53. The entity last dividend was issued on the 7th of November 2024. The firm had 2:1 split on the 31st of August 2010. Based on the measurements of operating efficiency obtained from ResMed's historical financial statements, ResMed Inc may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.16 | 0.2817 |
|
| |||||
| Total Cash From Operating Activities | 1.5 B | 1.4 B |
|
| |||||
| Operating Income | 1.4 B | 1.3 B |
|
|
ResMed Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. ResMed has an asset utilization ratio of 68.18 percent. This indicates that the Company is making $0.68 for each dollar of assets. An increasing asset utilization means that ResMed Inc is more efficient with each dollar of assets it utilizes for everyday operations.ResMed Ownership Allocation
ResMed owns a total of 146.8 Million outstanding shares. Over half of ResMed's outstanding shares are owned by third-party entities. These third-party entities are typically referred to as corporate investors that secure positions in a given instrument to benefit from reduced trade commissions. Please note that on December 6, 2024, Representative Ro Khanna of US Congress acquired under $15k worth of ResMed Inc's common stock.ResMed Profitability Analysis
The company reported the last year's revenue of 4.69 B. Total Income to common stockholders was 1.02 B with profit before taxes, overhead, and interest of 2.39 B.ResMed Past Distributions to stockholders
| 12th of December 2024 | ||
| 19th of September 2024 | ||
| 13th of June 2024 | ||
| 9th of May 2024 | ||
| 14th of March 2024 | ||
| 14th of December 2023 | ||
| 21st of September 2023 | ||
| 15th of June 2023 | ||
| 16th of March 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates ResMed's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in ResMed and how it compares across the competition.
About ResMed Valuation
The stock valuation mechanism determines ResMed's current worth on a weekly basis. Our valuation model uses a comparative analysis of ResMed. We calculate exposure to ResMed's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of ResMed's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 2.7 B | 2.8 B | |
| Pretax Profit Margin | 0.27 | 0.18 | |
| Operating Profit Margin | 0.28 | 0.16 | |
| Net Profit Margin | 0.22 | 0.13 | |
| Gross Profit Margin | 0.57 | 0.67 |
ResMed Quarterly Retained Earnings |
|
A single share of ResMed represents a small ownership stake in the entity. As a stockholder of ResMed, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
ResMed Dividends Analysis For Valuation
At present, ResMed's Dividend Payout Ratio is projected to increase slightly based on the last few years of reporting. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 3.70, whereas Dividends Paid is forecasted to decline to about 203 M. . At present, ResMed's Earnings Yield is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings Ratio is expected to grow to 27.94, whereas Retained Earnings Total Equity is forecasted to decline to about 2.3 B.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 282.3 M | 203 M | |
| Dividend Yield | 0.01 | 0.01 | |
| Dividend Payout Ratio | 0.28 | 0.44 | |
| Dividend Paid And Capex Coverage Ratio | 3.53 | 3.70 |
There are various types of dividends ResMed can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of ResMed shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from ResMed Inc directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When ResMed pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of ResMed by the value of the dividends paid out.
ResMed Growth Indicators
Investing in growth stocks can be very risky. If the company such as ResMed does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 147.6 M | |
| Quarterly Earnings Growth Y O Y | 0.416 | |
| Forward Price Earnings | 25.4453 |
ResMed Current Valuation Indicators
Valuation refers to the process of determining the present value of ResMed Inc and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value ResMed we look at many different elements of the entity such as ResMed's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as ResMed, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use ResMed's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes ResMed's worth.Complementary Tools for ResMed Stock analysis
When running ResMed's price analysis, check to measure ResMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ResMed is operating at the current time. Most of ResMed's value examination focuses on studying past and present price action to predict the probability of ResMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ResMed's price. Additionally, you may evaluate how the addition of ResMed to your portfolios can decrease your overall portfolio volatility.
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |